Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer

eBioMedicine(2024)10.1016/j.ebiom.2024.105356Source: DataRank Database

Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer is a research paper published in eBioMedicine (2024). On theSindex it has a DataRank of 0.385. It has been cited 12 times.

N/A

0.385DataRank · unranked

Scored on demand from live citation data

12 citations

Download PDF

Cite:

Linked data & code

cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 3.29)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.385

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Cao Dai Phung,Brendon Z.J. Yeo,Rebecca C. Prajogo ORCID,Migara K. Jayasinghe,Ju Yuan

Live enrichment

PubMed:39303667 PMC:PMC11437961 OpenAlex:https://openalex.org/W4402636257

National Research Foundation of Singapore

Grant: NRF-CRP23-2019-0004

National Research Foundation of Singapore

Grant: NRF-NRFI08-2022

National Research Foundation of Singapore

Grant: NRF-CRP22-2019-0003

National Medical Research Council

Grant: NMRC/OFLCG/002-2018

National Medical Research Council

Grant: NMRC/OFIRG/ MOH-000643-00

National Medical Research Council

Grant: OFYIRG22jul-0034

National Medical Research Council

Grant: OFIRG21nov-0068

Ministry of Health -Singapore

Agency for Science, Technology and Research

Ministry of Education - Singapore

FWCI

3.29

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.ebiom.2024.105356

publisherhttps://doi.org/10.1016/j.ebiom.2024.105356

publisherhttps://api.elsevier.com/content/article/PII:S235239642400392X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S235239642400392X?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39303667

Fields of Study

Lung Cancer Treatments and MutationsExtracellular vesicles in diseaseLung Cancer Research StudiesCarcinoma, Non-Small-Cell LungHumansErbB ReceptorsOligonucleotides, AntisenseLung NeoplasmsAnimalsMutationMiceCell Line, TumorXenograft Model Antitumor AssaysPrecision MedicineDrug Resistance, NeoplasmExtracellular VesiclesDisease Models, AnimalProtein Kinase InhibitorsAntineoplastic Agents

MeSH Terms

Extracellular VesiclesAnimalsAntineoplastic AgentsCarcinoma, Non-Small-Cell LungDisease Models, AnimalHumansLung NeoplasmsMutationOligonucleotides, AntisenseDrug Resistance, NeoplasmXenograft Model Antitumor AssaysCell Line, TumorProtein Kinase InhibitorsMicePrecision MedicineErbB Receptors

Keywords

OligonucleotideMutantCancer researchLung cancerMedicineCellComputational biologyBiologyGeneOncologyGeneticsEGFRAntisense oligonucleotidesCancer therapyNon-small cell lung cancerExtracellular Vesicles

Sustainable Development Goals

SDG 0: Good health and well-being